Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy

Megan Crane; Anchalee Avihingsanon; Reena Rajasuriar; Pushparaj Velayudham; David Iser; Ajantha Solomon; Baotuti Sebolao; Andrew Tran; Tim Spelman; Gail Matthews; Paul Cameron; Pisit Tangkijvanich; Gregory J Dore; Kiat Ruxrungtham; Sharon R Lewin

Journal article

Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy

Megan Crane, Anchalee Avihingsanon, Reena Rajasuriar, Pushparaj Velayudham, David Iser, Ajantha Solomon, Baotuti Sebolao, Andrew Tran, Tim Spelman, Gail Matthews, Paul Cameron, Pisit Tangkijvanich, Gregory J Dore, Kiat Ruxrungtham, Sharon R Lewin

The Journal of Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2014

DOI: 10.1093/infdis/jiu119

University of Melbourne Researchers

Reena Rajasuriar Author Doherty Institute

Paul Cameron Author Doherty Institute

Timothy Spelman Author Surgery - St Vincent's Hospital

Sharon Lewin Author Doherty Institute

Related Projects (2)

Improved Health Outcomes For People Living With Hiv

Despite the success of antiviral therapy for HIV infection, HIV cannot be cured and treatment is life long. In addition, there are complicat..

Hiv-Hbv Co-Infection

Morbidity and mortality secondary to liver disease is greatly increased in people co-infected with HIV and HBV compared to those infected wi..

Grants

Awarded by National Health and Medicine Research Council (NHMRC)

Awarded by American Foundation

Funding Acknowledgements

This work was supported by the National Health and Medicine Research Council (NHMRC APP1024066 to M. C., S. R. L., and G. M.) and the American Foundation for AIDS Research Mathilde Krim Fellowship for Basic Biomedical Research (award 107962-49-RKGN to M. C.).